Mannheim Urology

Mannheim Pharma & Diagnostics is a medical technology and pharmaceutical company focused on the development of innovative diagnostic agents and monitoring systems for renal function. The company is best known for its collaboration on the MediBeacon Glomerular Filtration Rate (GFR) Monitoring System, which utilizes a proprietary fluorescent tracer agent to provide real-time, point-of-care measurement of kidney function without the need for blood or urine sampling. This technology aims to replace traditional, time-consuming estimation methods with precise, continuous monitoring in clinical settings. Mannheim Pharma & Diagnostics operates primarily out of Germany, supporting the clinical validation and commercialization of these advanced urological and nephrological diagnostic tools.